Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome
US9913818B2 · kind B2 · utility
12Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 3, 2014 |
| Grant date | Mar 13, 2018 |
| Priority date | — |
| Expiry date | Oct 3, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to compositions that comprise citrulline and leucine or a metabolite thereof including, for example, a synergistic amount of citrulline and leucine. Such compositions may be used in methods for the treatment of metabolic syndrome, hyperglycemia, and/or hyperinsulinemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.